Therapeutic targets for hepatocellular carcinoma identified using proteomics and Mendelian randomization
Journal of Gastroenterology and Hepatology · 2025
DOI: 10.1111/jgh.16785 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Weixiong Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Mendelian Randomization Analysis, Proteomics. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Major Science and Technology Projects of Gansu Province, Joint Research Fund General Projects of Gansu Province.
Abstract (Originalsprache)
Background and Aim Hepatocellular carcinoma (HCC) emerges as a formidable malignancy marked by elevated morbidity and mortality rates, coupled with a dismal prognosis. The revelation of gene–protein associations has presented an avenue for the exploration of novel therapeutic targets.
Methods
Pooling plasma proteomic data (seven published GWAS) and HCC data (DeCODE cohort), we applied MR to identify potential drug targets, which were further validated in the FinnGen cohort and UK Biobank. Subsequent colocalization and summary‐data‐based Mendelian randomization analyses were performed for potential associations of this set of proteins. In addition, enrichment information pathways were investigated in depth by KEGG pathway analysis, single‐cell sequencing, PPI and DGIdb, ChEMBL, and DrugBank database analyses, specific cell types enriched for expression were identified, interacting proteins were identified, and finally, druggability was assessed.
Results
In summary, the levels of 10 proteins are linked to HCC risk. Elevated levels of TFPI2 as well as decreased levels of ALDH1A1, KRT18, ADAMTS13, TIMD4, SCLY, HRSP12, TNFAIP6, FTCD, and DDC are associated with increased HCC risk. Notably, HRSP12 show the strongest evidence. These genes are primarily expressed in specific cell types within the HCC TME. Moreover, intricate protein–protein interactions, involving key players like ALDH1A1 and RIDA, ALDH1A1 and DDC, and ALDH1A1 and KRT18, contribute significantly to the amino acid metabolism and dopaminergic neurogenesis pathway. Proteins such as ALDH1A1, KRT18, TFPI2, and DDC are promising targets for HCC therapy and broader cancer drug development. Targeting these proteins offers substantial potential in advancing HCC treatment strategies.
Conclusions
This research delineates 10 protein biomarkers linked to HCC risk and offers novel perspectives on its etiology, as well as promising avenues for the screening of HCC protein markers and therapeutic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.
- Department of General Surgery, The Second Hospital of Lanzhou University, Lanzhou, China.
- Nanchang Central Hospital, Jiangxi Provincial University of Traditional Chinese Medicine, nanchang, 330000, China.
ORCID-Profile: Jianqi Qin, Wence Zhou
Förderung
- National Natural Science Foundation of China
- Major Science and Technology Projects of Gansu Province
- Joint Research Fund General Projects of Gansu Province
- Science and Technology Program of Gansu Province
- Inner Mongolia Autonomous Region 642 Health, Science and Technology Plan Project
Zitieren
APA
Zhu, W., Fan, C., Liu, B., Qin, J., Fan, A., Yang, Z., Zhang, H., & Zhou, W. (2025). Therapeutic targets for hepatocellular carcinoma identified using proteomics and Mendelian randomization. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16785
Vancouver
Zhu W, Fan C, Liu B, Qin J, Fan A, Yang Z, et al. Therapeutic targets for hepatocellular carcinoma identified using proteomics and Mendelian randomization. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.16785
BibTeX
@article{Zhu2025,
author = {Zhu, Weixiong and Fan, Chuanlei and Liu, Bo and Qin, Jianqi and Fan, Aodong and Yang, Zengxi and Zhang, Hui and Zhou, Wence},
title = {Therapeutic targets for hepatocellular carcinoma identified using proteomics and Mendelian randomization},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
doi = {10.1111/jgh.16785}
}
EUVIMED